Self-Limiting Conditions Independent Study Program – College of Pharmacists of Manitoba

Upon successful completion of this self-study, the pharmacist will be able to:

1. Describe and apply the Manitoba regulations and practice directions related to pharmacist prescribing for self-limiting conditions.
2. Describe the pathophysiology of the self-limiting conditions listed in Schedule 3 to the Pharmaceutical Regulation including atopic dertmatitis, allergic contact dermatitis, irritant contact dermatitis, urticaria; acne vulgaris; tinea pedis; candidal stomatitis; unspecified haemorrhoids without complication; vasomotor and allergic rhinitis; seborrhoeic dermatitis (excluding pediatric); recurrent oral aphthae; and vomiting of pregnancy, unspecified.
3. Recognize the signs and symptoms of the conditions and identify red flags.
4. Appropriately assess and evaluate a patients symptoms to determine if treatment is suitable or if referral is necessary.
5. Determine the most effective course of action (treatment, referral, or reassurance) and communicate this with the patient.
6. Educate the patient on the correct use of drugs or treatment.
7. Educate the patient on the possible non-pharmacological measures.
8. Provide accurate goals of therapy and monitoring parameters to the patient.